National Institute of Child Health and Human Development; Notice of Meeting, 47504-47505 [06-6965]
Download as PDF
<![CDATA[
47504
Federal Register / Vol. 71, No. 159 / Thursday, August 17, 2006 / Notices
the statement of the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/ncab.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6964 Filed 8–16–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rwilkins on PROD1PC63 with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meetings of the
National Advisory Neurological
Disorders and Stroke Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Training Career Development and
Special Programs Subcommittee.
Date: September 13, 2006.
VerDate Aug<31>2005
16:36 Aug 16, 2006
Jkt 208001
Open: 8 p.m. to 10 p.m.
Agenda: To discuss the training programs
of the Institute.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Stephen J. Korn, PhD,
Training and Special Programs Officer,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2154, MSC 9527,
Bethesda, MD 20892–9527, (301) 496–4188.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Basic and Preclinical Programs
Subcommittee.
Date: September 14, 2006.
Open: 8 a.m. to 9 a.m.
Agenda: To discuss basic and preclinical
programs policy.
Place: National Institutes of Health,
Building 31, A Wing, 31 Center Drive,
Conference Room 8A–28, Bethesda, MD
20892.
Closed: 9 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, A Wing, 31 Center Drive,
Conference Room 8A–28, Bethesda, MD
20892.
Contact Person: Robert Baughman, MD,
Associate Director for Technology
Development, National Institute of
Neurological Disorders and Stroke, National
Institutes of Health, 6001 Executive Blvd.,
Suite 2137, MSC 9527, Bethesda, MD 20892–
9527, (301) 496–1779.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council,
Council Clinical Trials Subcommittee.
Date: September 14, 2006.
Closed: 8 a.m. to 9 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C Wing, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Open: 9 a.m. to 10 a.m.
Agenda: To discuss clinical trials policy.
Place: National Institutes of Health,
Building 31, C Wing, 31 Center Drive,
Conference Room 10, Bethesda, MD 20892.
Contact Person: John Marler, MD,
Associate Director for Clinical Trials,
National Institute of Neurological Disorders
and Stroke, National Institutes of Health,
6001 Executive Blvd., Suite 2216, Bethesda,
MD 20892, (301) 496–9135, jm137f@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: August 9, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6962 Filed 8–16–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Child Health and
Human Development Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Child Health and Human Development
Council.
Date: September 11, 2006.
Open: 8 a.m. to 12:30 p.m.
Agenda: (1) A report by the Director,
NICHD; (2) a report of the Subcommittee on
Planning and Policy; (3) Developmental
Biology, Genetics and Teratology Branch
presentation; and other business of the
Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C–Wing,
Conference Room 6, Bethesda, MD 20892.
Closed: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C–Wing,
Conference Room 6, Bethesda, MD 20892.
E:\FR\FM\17AUN1.SGM
17AUN1
Federal Register / Vol. 71, No. 159 / Thursday, August 17, 2006 / Notices
Contact Person: Yvonne T. Maddox, PhD,
Deputy Director, National Institute of Child
Health and Human Development, NIH, 9000
Rockville Pike MSC 7510, Building 31, Room
2A03, Bethesda, MD 20892, (301) 496–1848.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/nachhd.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: August 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6965 Filed 8–16–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Toxicology Program (NTP),
NTP Interagency Center for the
Evaluation of Alternative Toxicological
Methods (NICEATM): Scientific
Workshop on Alternative Methods To
Refine, Reduce, or Replace the Mouse
LD50 Assay for Botulinum Toxin
Testing; Request for In Vivo and In
Vitro Data
National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health
(NIH), Department of Health and Human
Services.
ACTION: Workshop announcement and
data request.
rwilkins on PROD1PC63 with NOTICES
AGENCY:
SUMMARY: The Interagency Coordinating
Committee on the Validation of
Alternative Methods (ICCVAM) and
NICEATM announce an upcoming
‘‘ICCVAM/NICEATM/ECVAM Scientific
Workshop on Alternative Methods to
VerDate Aug<31>2005
16:36 Aug 16, 2006
Jkt 208001
Refine, Reduce, or Replace the Mouse
LD50 Assay for Botulinum Toxin
Testing.’’ The workshop is being coorganized by ICCVAM, NICEATM, and
the European Centre for the Validation
of Alternative Methods (ECVAM). This
workshop is open to the public with
attendance limited only by the space
available. ICCVAM and NICEATM also
invite the submission of (1) data from
botulinum toxin test methods and (2)
abstracts for scientific posters for
display at the workshop (discussed
more under ‘‘Supplemental
Information’’).
The workshop will be held on
November 13 and 14, 2006. Sessions for
both days will begin at approximately
8:30 a.m. and end at approximately 5
p.m. The deadline for submission of an
abstract is September 29, 2006. The
deadline for submission of data is
October 20, 2006.
Individuals who plan to attend the
workshop are strongly encouraged to
register in advance (by October 30,
2006) with NICEATM. Registration
information, an agenda, and additional
information will be available on the
workshop Web site (https://
iccvam.niehs.nih.gov/methods/
biolodocs/biolowkshp/wkshpinfo.htm)
and upon request from NICEATM (see
‘‘FOR FURTHER INFORMATION CONTACT’’
above).
DATES:
The workshop will be held
at the Crowne Plaza Hotel, 8777 Georgia
Avenue, Silver Spring, MD 20910.
Persons needing special assistance, such
as sign language interpretation or other
reasonable accommodation in order to
attend, should contact 919–541–2475
(voice), 919–541–4644 TTY (text
telephone), through the Federal TTY
Relay System at 800–877–8339, or email to niehsoeeo@niehs.nih.gov.
Requests should be made at least 7 days
in advance of the event.
FOR FURTHER INFORMATION CONTACT:
Correspondence should be addressed to
Dr. William S. Stokes, NICEATM
Director, NIEHS, P.O. Box 12233, MD
EC–17, Research Triangle Park, NC
27709, (phone) 919–541–2384, (fax)
919–541–0947, (e-mail)
niceatm@niehs.nih.gov.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Background
In October 2005, the Humane Society
of the United States (HSUS) submitted
a nomination to NICEATM to organize
a workshop to evaluate the state-of-thescience for potential alternatives to the
mouse LD50 assay for botulinum toxin
potency testing. The HSUS nomination
is available at https://
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
47505
iccvam.niehs.nih.gov. See ‘‘Nominations
and Submissions.’’ ICCVAM considered
the nomination and supported, with a
high priority, the concept of a workshop
to discuss alternative methods and
approaches that might reduce, refine, or
replace the use of animals for botulinum
toxin potency testing. The Scientific
Advisory Committee on Alternative
Toxicological Methods (SACATM)
discussed this nomination at its meeting
on December 12, 2005, and concurred
with ICCVAM. The goals of the
workshop are to (1) review the state-ofthe-science and current status of
alternative methods that may refine (less
pain and distress), reduce, or replace the
use of mice for botulinum toxin testing
and (2) identify priorities for research,
development, and validation efforts
needed to advance the use of alternative
methods for botulinum toxicity testing.
Preliminary Workshop Agenda
Day 1
Monday, November 13, 2006
• Welcome and Introduction of
Workshop Goals and Objectives.
• Session 1 Overview of Public
Health Needs for Botulinum Toxin
Testing and Regulatory Requirements.
• Session 2 Current Understanding
and Knowledge Gaps for Botulinum
Toxin.
• Session 3 Potential Replacement
of Animal Use for Botulinum Toxin
Potency Testing.
Day 2
Tuesday, November 14, 2006
• Session 4 Refinement (Less Pain
and Distress) of Animal Use for
Botulinum Toxin Potency Testing.
• Session 5 Reduction of Animal
Use For In Vivo Botulinum Testing.
• Session 6 Wrap-up of Panel
Discussions.
Call for Abstracts
ICCVAM and NICEATM invite the
submission of abstracts for scientific
posters to be displayed during the
workshop. Posters should address
current developments and/or the
validation status of alternative test
methods for in vivo botulinum toxin
tests and their potential to reduce,
refine, or replace the use of the mouse
LD50 assay. The body of the abstract is
limited to 400 words or less and key
references relevant to the abstract may
be included after the abstract body.
However, the length of the abstract and
references should not exceed one page.
All submissions should be in at least 12point font and all margins for the
document should be no smaller than
one inch. Title information should
include the names of all authors and
their affiliations. The name and contact
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 71, Number 159 (Thursday, August 17, 2006)]
[Notices]
[Pages 47504-47505]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6965]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and Human Development; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory Child Health and Human Development Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Child Health and Human
Development Council.
Date: September 11, 2006.
Open: 8 a.m. to 12:30 p.m.
Agenda: (1) A report by the Director, NICHD; (2) a report of the
Subcommittee on Planning and Policy; (3) Developmental Biology,
Genetics and Teratology Branch presentation; and other business of
the Council.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C-Wing, Conference Room 6, Bethesda, MD 20892.
Closed: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C-Wing, Conference Room 6, Bethesda, MD 20892.
[[Page 47505]]
Contact Person: Yvonne T. Maddox, PhD, Deputy Director, National
Institute of Child Health and Human Development, NIH, 9000 Rockville
Pike MSC 7510, Building 31, Room 2A03, Bethesda, MD 20892, (301)
496-1848.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.nichd.nih.gov/about/nachhd.htm, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: August 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-6965 Filed 8-16-06; 8:45 am]
BILLING CODE 4140-01-M
